We are live on ! Find out more
WI

Wafra Inc Portfolio holdings

AUM $5.88M
1-Year Est. Return 19.88%
This Fund
S&P 500
This Quarter Est. Return
-13.17%
1 Year Est. Return
-19.88%
3 Year Est. Return
-45.92%
5 Year Est. Return
-39.46%
10 Year Est. Return
+57.28%
AUM
$2.55B
AUM Growth
-$381M
Cap. Flow
+$11M
Cap. Flow %
0.43%
Top 10 Hldgs %
71.1%
Holding
94
New
9
Increased
20
Reduced
11
Closed
12

Sector Composition

Rank Sector Weight
1 Miscellaneous 63.29%
2 Healthcare 6.11%
3 Communication Services 5.16%
4 Financials 5.13%
5 Technology 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
76
Stryker
SYK
$109B
$314K 0.01%
2,004
SARA
77
DELISTED
SARATOGA RESOURCES INC
SARA
$16K ﹤0.01%
780,483
DFS
78
DELISTED
Discover Financial Services
DFS
-198,078
Closed -$15.1M
DVN icon
79
Devon Energy
DVN
$53.3B
-285,655
Closed -$11.4M
GILD icon
80
Gilead Sciences
GILD
$183B
-328,125
Closed -$25.3M
HAL icon
81
Halliburton
HAL
$28.8B
-12,335
Closed -$500K
LEN icon
82
Lennar Class A
LEN
$18.9B
-243,261
Closed -$11M
LH icon
83
Labcorp
LH
$26.3B
-106,485
Closed -$15.9M
MLM icon
84
Martin Marietta Materials
MLM
$35.3B
-47,800
Closed -$8.7M
SPGI icon
85
S&P Global
SPGI
$120B
-9,872
Closed -$1.93M
VTLE
86
DELISTED
Vital Energy
VTLE
-24,722
Closed -$4.04M
SOGO
87
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
-288,569
Closed -$2.14M
WBC
88
DELISTED
WABCO HOLDINGS INC.
WBC
-59,731
Closed -$7.04M

Similar funds

Wafra Inc's Q4 2018 Portfolio in Review

As of Q4 2018, Wafra Inc held 94 positions worth $2.55B, down 13% from $2.93B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Wafra Inc's Q4 2018 filing shows 9 new, 20 increased, 11 reduced and 12 closed positions. Its largest new stake was CVS Health: 184,755 shares worth $12.1M. The largest sale was Gilead Sciences, an estimated $25.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 63% a quarter earlier, followed by Healthcare and Communication Services.

  • Wafra Inc's largest Q4 2018 buy was CVS Health: 184,755 shares worth $12.1M.
  • Wafra Inc added most to Vanguard FTSE Emerging Markets ETF in Q4 2018, an estimated $29.1M increase.
  • Wafra Inc's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21.5M.
  • Wafra Inc fully exited Gilead Sciences in Q4 2018, selling an estimated $25.3M.
  • Wafra Inc's ten largest holdings make up 71% of its $2.55B portfolio in Q4 2018.
  • Wafra Inc opened 9 new positions and closed 12 in Q4 2018.
  • Wafra Inc's portfolio value fell 13% quarter-over-quarter to $2.55B.

Based on Wafra Inc's 13F filing for Q4 2018, filed 13 Feb 2019.